Rapamycin, metformin, and fisetin are all associated with improvements in markers associated with aging. We are now beginning to see them used by healthy individuals interested in longevity. Daniel Tawfik is the founder, developer, and CEO of HealthSpan. HealthSpan optimizes human performance through interventions that target cellular senescence. Healthspan was created to empower patients to regain control over the levers of aging that are at the foundation of most age-related diseases.

Daniel holds a BS degree from UCLA in molecular, cellular, and developmental biology and physics. Daniel did his graduate research at UCLA's Protein Expression Technology Center where he studied neurometabolic disorders. 

http://dantawfik.com/

Gethealthspan.com 

@dantawfik

https://zenpatient.com/ 

⭐ Enjoying the show? Please leave a 5-star review on Apple Podcasts — it takes 30 seconds and helps more people discover the science of health and longevity. Thank you!

New episodes every other Tuesday. Subscribe so you don't miss one.

Continue this conversation on Substack: https://robertlufkinmd.substack.com
Lies I Taught In Medical School — Free sample chapter: https://www.robertlufkinmd.com/lies/

Web: https://www.robertlufkinmd.com
YouTube: https://www.youtube.com/robertlufkinmd
X: https://x.com/robertlufkinmd
Instagram: https://www.instagram.com/robertlufkinmd/
TikTok: https://www.tiktok.com/@robertlufkin
LinkedIn: https://www.linkedin.com/in/robertlufkinmd/